|
Inditherm plc ("Inditherm" or "the Company") , the provider of innovative
heating solutions, today reports its Preliminary Results for the 12 months ended
31 December 2006.
Summary
|
|
- Group turnover increased by 51% to £1,564k (2005:
£1,035k)
|
|
|
- Medical turnover up 146%: US distribution agreement with Smiths
Medical and appointment of seven other new distributors
|
|
|
- Industrial turnover up by 31%
|
|
|
- Post-tax loss, after exceptionals & net interest income, of
£1,132k (2005: £1,279k)
|
|
|
- Loss per share 5.4p (2005: 6.1p)
|
|
|
- Year end cash balance of £1,747k (2005: £2,363k)
|
|
|
- Cash placing in January 2007 puts Company on firm footing for the
future with a cash balance of £4,567k after the
placing
|
Commenting on the outlook, Mark Abrahams, Chairman of Inditherm, said:
"We have had a strong start to 2007, with a solid order book. Our primary
goal going forward is to reach break-even. Based upon our current prospects, I
am encouraged that this can be achieved."
For further information, please contact:
Media
enquiries:
Chairman's
Statement
Introduction
2006 was a year of transformation for Inditherm. Following the introduction
of our focused strategy to expand in the Industrial, Medical and Construction
sectors, emphasising larger projects, the first signs of success started to
emerge. The signing of the supply agreement with Smiths Medical, significant
orders for industrial process plants and a major pre-cast concreting project,
provided further encouragement.
The year culminated with the launch in December of a re-financing and
strengthening of the Balance Sheet (which was approved by the shareholders at an
Extraordinary General Meeting on 12 January 2007 ) by way of a Placing of
30,000,000 new Ordinary Shares at a price of 10 pence per Placing Share .
Following completion of the Placing, the issued share capital of the Company
increased to 51,112,581 Ordinary Shares and the Group's resources increased to
£4,567k immediately after the Placing.
Results
Turnover for the year rose by 51% to £1,564k (2005: £1,035k), mainly due to
growth in both Medical and Industrial sales. Orders received maintained the 71%
growth rate reported in the first half year.
The Industrial business showed continued growth in sales of 31%, which was
mainly driven by the successful introduction of our new modular pipework system,
accompanied by large tank heating installations. During the year we received
several larger orders for these systems from well-known confectionary and food
manufacturers. The value drivers for these systems are substantial energy
reductions, hygiene benefits and more rapid installation. Following a slow
start, towards the year end we saw an encouraging increase in work for UK water
utilities through the current Asset Management Programme (AMP4).
The Medical business grew by 146%, with 165% orders growth, helped at the
year end by a stock order from Smiths Medical. Purchases by the NHS improved and
the addition of 8 new overseas distributors contributed to the sustained growth
in exports. The new CosyTherm neo-natal warming product, launched towards the
end of 2005, has been well received in the market and sales are growing.
The Construction business made steady progress and obtained a large order for
precast concrete curing blankets. This demonstrated significant benefits for the
customer, including the ability to reduce the cement content of the concrete.
The project has acted as a valuable reference for other precast
manufacturers.
The cost base was reduced by 10% during the year, with all expenditure being
tightly controlled. Overheads before exceptional costs were £1,571k (2005:
£1,739k), resulting in an operating loss before exceptional costs of £1,087k
(2005: £1,402k). After restructuring and exceptional costs of £152k (2005: £50k)
and net interest income of £83k (2005: £138k), the post-tax loss was £1,132k
(2005: £1,279k).
The year end cash balance was £1,747k (2005: £2,363k). The cash placing on 15
January 2007 raised a further £2.8 million net of expenses. We believe that the
Company has sufficient funds to meet our current and medium term needs.
Dividends
As stated in previous years, it is the Board's intention to devote
the Company's financial resources to business development. This intention, which
the Board believes is in the shareholders' best interests, has been pursued
during 2006 and will continue for the foreseeable future. The Board therefore
does not expect to declare a dividend during the Company's continuing
development period.
Employees
Following the recent surge in quotation activity and orders, we have
responded by promoting a number of sales and operations people, followed by a
recruitment programme designed to maintain our growth momentum.
On behalf of the Board, I thank all our staff most sincerely for their
continued support.
Outlook
During recent months we have seen an encouraging increase in the level of
enquiries and orders. The order book at the start of the year has given us a
strong start and order intake for the first quarter of 2007 is up more than
40%.
Our industrial solutions are now well proven and have been embraced by
several key customers as the way forward for process heating, mainly due to the
energy saving and hygiene benefits.
The supply contract with Smiths Medical is expected to drive growth in our
Medical business and will supplement the growth anticipated from both domestic
and export sales of patient warming and neonatal products.
The Construction business is now well-established and there is growing
interest in our concrete curing products. The two year project funded by the
European FP6 CRAFT grant, previously reported, is yielding excellent results, as
well as orders from consortium partners.
Our initial goal going forward is to reach break-even. Based upon current
prospects, I am encouraged that this can be achieved.
Mark Abrahams Chairman 29 March 2007
Chief Executive's Review
Overview
During 2006 we focused on achieving top line growth, whilst keeping costs and
cash outflow under control. We continued to focus on our three main business
segments of Industrial, Medical and Construction, adding new products and
systems, and gaining credibility as a solutions provider with a number of major
international customers.
The supply agreement with Smiths Medical is a major endorsement of our
patient warming technology and provides the platform for substantial growth in
our Medical business during 2007.
The cash placing has given us the opportunity to invest in additional sales
and technical resources and means that we can accelerate the growth
opportunities.
Industrial
Sales in the Industrial segment increased by 31% over 2005, and orders by
45%, mainly due to growth in process heating orders for our new modular pipework
systems and associated tank heaters.
We received several orders for larger heating installations from well known
manufacturers for heating chocolate, sugars and chemicals. One of these was
installed in Poland , where we demonstrated our ability to manage such projects
by completing ahead of schedule. The key value propositions of these modular
systems are the shortened installation time, improved hygiene, energy savings,
controllability and improved production output. Energy savings as a result of
using Inditherm, now verified by several of our customers, can be as high as 75%
on a like-for-like basis. In order to retain our focus on our core competencies,
we have chosen to subcontract areas such as pipework and cladding to competent
partners, albeit at lower margins.
During the year we signed a framework agreement with Yorkshire Water and
carried out successful trials for heating sewerage sludge transfer lines with
Severn Trent Water. After a slow start in 2005, we are now receiving regular
water utility orders under the AMP4 Asset Management Programme.
During the year we appointed more overseas distributors and since the cash
placing, have strengthened the industrial sales organisation with the
recruitment of additional sales resources.
Medical
Medical orders increased by 165% and sales by 146%, helped by the first stock
order from Smiths Medical in December. Deliveries to Smiths have now commenced
and they have now placed a further order for delivery in the second quarter.
During the year we appointed eight new overseas distributors.
Sales to the NHS have picked up and we are now recognised as providing a
highly cost-effective solution. We have recently strengthened our UK Medical
sales force.
Sales of the CosyTherm neonatal warming system have grown well and we are
also pursuing international distribution opportunities.
Construction
The Construction business had an encouraging year, with the successful
installation of a major concrete curing system for a large pre-caster. This
really highlighted the benefits of our system: more rapid curing, improved
hydration and early strength development, significantly reduced energy cost
(typically 80% or more), the opportunity to reduce cement content, along with a
range of operational benefits.
Other projects included supplying curing blankets for rapid runway repairs at
a major UK airport.
Other Activities
Our standard product lines, notably vessel heaters and heating pads for pizza
and curry bags, have continued to grow during the year, providing a good base
load of work.
Whilst our existing under-pitch heating installations continue to operate
well and we continue to pursue those opportunities that arise from time to time,
this is no longer a key area of focus, due to the sporadic nature of this
market.
Operations
Our efforts to reduce overhead spend continued throughout the year, with
substantial reductions being achieved. Despite the additional headcount now in
place, our first quarter overheads in 2007 are 13% lower than the same period in
2006 and 9% lower than in 2005.
Our project management capabilities were put to the test on a number of large
projects and in each case, we were able to delight our customers by completing
the work on or ahead of schedule.
Product Development
Product development work continued in all main business sectors during the
year. Further improvements were made to our Industrial products, notably
enhancements and options for our modular pipework systems.
There were ongoing improvements made to our Medical products and some new
products based upon our proven technology are also in the pipeline.
The concrete curing R&D project under the European FP6 CRAFT programme,
previously reported, has gone well, further validating the technology and
providing valuable technical data. Cooperation agreements are being negotiated
with some members of the trans-European consortium.
During the year we formed a partnership with Grant Rail and Sheffield Hallam
University to develop a system for heating railway track, so that it can be
welded more easily. This was supported by a Yorkshire Forward grant. Initial
field test results have been encouraging.
Outlook
The agreement with Smiths Medical provides an excellent platform for growth.
Medical production rates have been increased to meet our commitments.
Based upon enquiries and recent order flow, Industrial sales are expected to
exceed the growth rate seen last year, mainly due to the market acceptance of
our modular pipework and tank heating technology. It appears that Inditherm is
no longer seen as a high risk purchase, and we are now moving from technical to
commercial acceptance. The growing interest in energy savings and the greater
emphasis on hygiene among food manufacturers are also expected to drive demand.
More widespread deployment of standard products will facilitate growth in
international sales through our distributor network. Water utility work
continues to rise and with more field sales people now in place, we intend to
pursue the all the major Water Utilities throughout the UK .
Now that we have some good reference sites, the Construction sector is
expected to see significant growth in 2007, particularly for pre-cast concrete
curing applications.
Our initial goal is to reach break-even as fast as possible and our entire
team is focused on achieving this.
The challenges facing Inditherm in 2007 remain considerable but so are the
opportunities. We have started the year with a substantial order book which has
given us a solid start to the year.
Richard Harpum Chief Executive 29 March 2007
Preliminary announcement of results for the year ended 31 December
2006
Consolidated profit and loss account
|
2006 |
|
2005 |
|
|
|
|
|
£'000 |
|
£'000 |
|
|
|
|
|
|
|
|
|
Turnover |
1,564 |
|
1,035 |
|
|
|
|
|
Cost of Sales |
(1,155) |
|
(698) |
|
|
|
|
|
|
|
|
|
Gross Profit |
409 |
|
337 |
|
|
|
|
|
Administrative expenses |
(1,648) |
|
(1,789) |
|
|
|
|
|
|
|
|
|
Operating loss before exceptional costs |
(1,087) |
|
(1,402) |
|
Exceptional costs |
(152) |
|
(50) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating loss |
(1,239) |
|
(1,452) |
|
|
|
|
|
Interest receivable |
84 |
|
139 |
|
Interest payable |
(1) |
|
(1) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss on ordinary activities before
taxation |
(1,156) |
|
(1,314) |
|
|
|
|
|
|
|
|
|
Tax credit from loss on ordinary activities |
24 |
|
35 |
|
|
|
|
|
|
|
|
|
Sustained deficit for the year |
(1,132) |
|
(1,279) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss per share-basic and diluted |
(5.4)p |
|
(6.1)p |
|
|
|
|
|
|
|
|
All amounts relate to continuing activities.
All recognised gains and losses are included within the
profit and loss account.
Preliminary announcement of
results for the year ended 31 December 2006
Consolidated balance sheet
|
|
|
2006 |
|
2005 |
|
|
|
|
|
|
As Restated |
|
|
|
|
|
|
|
|
|
|
|
£'000 |
£'000 |
|
£'000 |
£'000 |
|
|
|
|
|
|
|
|
|
Fixed Assets |
|
|
|
|
|
|
|
Intangible Assets |
|
29 |
|
|
43 |
|
|
Tangible Assets |
|
209 |
|
|
270 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
238 |
|
|
313 |
|
|
|
|
|
|
|
|
|
Current Assets |
|
|
|
|
|
|
|
Stocks |
121 |
|
|
200 |
|
|
|
Debtors |
291 |
|
|
292 |
|
|
|
Investment |
- |
|
|
250 |
|
|
|
Cash at bank and in hand |
1,747 |
|
|
2,363 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,159 |
|
|
3,105 |
|
|
|
|
|
|
|
|
|
|
Creditors: amounts falling due within one
year |
(583) |
|
|
(311) |
|
|
|
|
|
|
|
|
|
|
Net current assets |
|
1,576 |
|
|
2,794 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total assets less current
liabilities |
|
1,814 |
|
|
3,107 |
|
|
|
|
|
|
|
|
|
Provision for liabilities |
|
(107) |
|
|
(268) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net assets |
|
1,707 |
|
|
2,839 |
|
|
|
|
|
|
|
|
Capital and reserves |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Called up share capital |
|
211 |
|
|
211 |
|
|
Share premium |
|
7,423 |
|
|
7,423 |
|
|
Other reserves |
|
50 |
|
|
50 |
|
|
Share based payment reserve |
|
60 |
|
|
60 |
|
|
Profit and loss account |
|
(6,037) |
|
|
(4,905) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shareholders' funds |
|
1,707 |
|
|
2,839 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preliminary announcement of
results for the year ended 31 December 2006
Consolidated cash flow statement
|
|
|
2006 |
|
2005 |
|
|
|
£'000 |
£'000 |
|
£'000 |
£'000 |
|
|
|
|
|
|
|
|
|
Net cash outflow from operating
activities |
|
(983) |
|
|
(1,340) |
|
|
|
|
|
|
|
|
|
Returns on investments and servicing of
finance |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest received |
84 |
|
|
139 |
|
|
|
Interest element of hire purchase payments |
(1) |
|
|
(1) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash inflow from returns on
investments and servicing of finance |
|
83 |
|
|
138 |
|
|
|
|
|
|
|
|
|
Taxation |
|
24 |
|
|
35 |
|
|
|
|
|
|
|
|
|
Capital expenditure and financial
investment |
|
|
|
|
|
|
|
Purchase of tangible fixed assets |
(19) |
|
|
(60) |
|
|
|
Sale of Investment bonds |
284 |
|
|
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash outflow from capital expenditure
and financial investment |
|
265 |
|
|
(60) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash outflow before
management of liquid resources and financing |
|
(611) |
|
|
(1,227) |
|
|
|
|
|
|
|
|
|
Management of liquid resources |
|
|
|
|
|
|
|
Decrease in cash on short-term deposit |
|
695 |
|
|
1,208 |
|
|
|
|
|
|
|
|
|
Financing |
|
|
|
|
|
|
|
Issue of shares |
- |
|
|
14 |
|
|
|
Capital element of hire purchase payments |
(5) |
|
|
(14) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash outflow from financing |
|
(5) |
|
|
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Increase/(Decrease) in cash |
|
79 |
|
|
(19) |
|
|
|
|
|
|
|
|
Preliminary announcement of
results for the year ended 31 December 2006
Consolidated cash flow
statement (continued)
|
Reconciliation of operating loss to net
cash outflow from operating activities |
|
|
|
|
|
|
|
2006 |
|
2005 |
|
|
£'000 |
|
£'000 |
|
|
|
|
|
|
Operating loss |
(1,239) |
|
(1,452) |
|
Profit on disposal of current asset
investment |
(34) |
|
- |
|
Depreciation and amortisation |
94 |
|
92 |
|
Loss on disposal of fixed assets |
- |
|
5 |
|
Decrease in stocks |
79 |
|
24 |
|
Decrease in debtors |
1 |
|
215 |
|
Increase/(decrease) in creditors |
277 |
|
(220) |
|
Decrease in provisions |
(161) |
|
(4) |
|
|
|
|
|
|
|
|
|
|
|
|
(983) |
|
(1,340) |
|
|
|
|
|
|
Analysis of changes in net funds |
|
|
|
|
|
|
|
01-Jan |
|
Cashflow |
|
31-Dec |
|
|
2006 |
|
|
|
2006 |
|
|
|
|
|
|
|
|
£'000 |
|
£'000 |
|
£'000 |
|
|
|
|
|
|
|
Cash at bank and in hand |
2,363 |
|
(616) |
|
1,747 |
|
Less: Term deposits treated as liquid
resources |
(2,364) |
|
695 |
|
(1,669) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
79 |
|
78 |
|
|
|
|
|
|
|
|
Obligations under hire purchase contracts |
(5) |
|
5 |
|
- |
|
Term deposits |
2,364 |
|
(695) |
|
1,669 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,358 |
|
(611) |
|
1,747 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preliminary announcement of
results for the year ended 31 December 2006
Consolidated cash flow
statement (continued)
|
Reconciliation of net cash flow to
movement in net funds |
|
|
|
|
|
|
|
|
|
|
2006 |
|
2005 |
|
|
£'000 |
|
£'000 |
|
|
|
|
|
|
Increase/(decrease) in cash in year |
79 |
|
(19) |
|
Cash outflow from decrease in debt |
5 |
|
14 |
|
Cash inflow from decrease in liquid
resources |
(695) |
|
(1,208) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Decrease in net funds from cash flows |
(611) |
|
(1,213) |
|
|
|
|
|
|
|
|
|
|
|
Net funds at the beginning of the year |
2,358 |
|
3,571 |
|
|
|
|
|
|
|
|
|
Net funds at the end of the year |
1,747 |
|
2,358 |
|
|
|
|
|
|
|
|
|
|
NOTES
-
The preliminary results have been
prepared under the historical cost convention, in accordance with applicable
Accounting Standards in the United Kingdom and with the company's accounting
policies as set out in the financial statements for the year ended 31 December
2005 with the exception of the adoption of FRS 20 in the year. The preliminary
results were approved by the Board on 28 March 2007 and are unaudited. The
financial information contained in this unaudited preliminary announcement
statement does not constitute accounts as defined by Section 240 of the
Companies Act 1985. The financial information for the year ended 31 December
2005 is derived from the statutory accounts for that year which
have been delivered to the Registrar of Companies. The auditors reported on
those accounts; their report was unqualified and did not contain a statement
under either Section 237 (2) or Section 237 (3) of the Companies Act 1985. The
statutory accounts for the year ended 31 December 2006 and the auditors report
thereon will be finalised based on the information in this preliminary
announcement and will be delivered to the Registrar of Companies following the
company's AGM.
-
The calculation of loss per
ordinary share is based on losses of £1,132,000 (2005: £1,279,000) and on a
weighted average of 21,112,581 (2005: 21,073,948) ordinary shares in issue
during the year. The share options are anti-dilutive due to the loss in the
year.
-
Copies of the 2006 Annual Report
and Accounts will be sent to all shareholders. Copies will be available from
the Company Secretary at Inditherm plc, Inditherm House, Houndhill Park , Bolton
Road , Wath upon Dearne, Rotherham ,
S63 7LG
.
-
On 15 January 2007 the company issued
30,000,000 new ordinary shares of 1p each for a consideration of 10p per
share. The company received £2.8m net of expenses.
-
Exceptional costs of £152k arose
during the year. £75k has been provided for the costs of upgrading patient
warming systems to include additional safety features to detect damage to the
product caused by misuse or storage in a method contrary to operating
instructions. £57k arose as a result of the Corporate finance work associated
with pursuing strategic options to secure additional funding. £20k was
incurred as compensation for loss of office.
-
In accordance with FRS 20 the fair
value of equity settled share-based payments to employees are determined at
the date of grant and have been charged against profit over the period the
options have vested. The accounts for the relevant period (2004) have been
restated and a share based payment reserve of £60,000 has been created. The
adoption of FRS 20 represents a change in accounting policy the impact of
which has been to reduce net assets at 31 December 2005 and 2006 by
£60,000. There was no impact on reported profit in either
year.
|